acquired
Stage
4
Investors
About
Voluntis developed and commercialized digital therapeutics (DTx) designed to help patients with chronic diseases manage their conditions. These software solutions provided personalized guidance and support to improve patient outcomes.
Explore Voluntis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.